Authors
Latest:
Accelerating the Progress of Kinase Inhibitors in OncologyThe potential of PBPK modeling in answering key questions around these drugs.
Latest:
Accelerate Clinical Trial Success with Genomics ExpertsWebinar Date/Time: Thu, Mar 2, 2023 1:00 PM EST
Latest:
Improving Diversity in Clinical TrialsEmploying a Multi-faceted Approach to Cultivate Inclusivity and Close Disparity.
Latest:
Innovations in Data Capture Transforming Trial DeliveryAdvances in technology open door for improved EHR to EDC transfer process.
Latest:
Considerations to Reach Underrepresented GroupsRegulatory compliance, collaboration, and effective use of technology among ways CROs can overcome challenges.
Latest:
Assessing Investigative Site Outlook and Operating Experience Post-PandemicTufts CSDD survey finds fostering healthy relationships with site staff is key to a positive outlook.
Latest:
3 Ways to Turn Client Experience into Your Competitive Advantage*** Thursday, March 11, 2021 at 11am EST | 8am PST | 4pm GMT | 5pm CET *** How can CROs continue to grow in today’s increasingly competitive market? Learn how you can turn client experience into your competitive advantage. *** On demand available after final airing until Mar. 11, 2022 ***
Latest:
Opportunities for Improving Clinical Decisions with Patient Centric Remote Blood Sampling ApproachesThis article sets out a vision of adopting convenient alternative blood sampling approaches that places the needs of the patient at the center and enables active monitoring, before the onset of clinical events, leading to improved healthcare.
Latest:
Future of Clinical Trial Documentation Management: eTMF Integrated with BlockchaineTMF-blockchain technology offers a myriad of application benefits to data quality and integrity while ensuring compliance to ethical standards.
Latest:
Central RBM Supports Reduced Cost, Higher Data QualityImplementing centralized risk-based monitoring can help meet strict GCP requirements for study conduct, oversight, and recording.
Latest:
What the Future of Study Review Processes Should Look LikeInsights from Bayer’s study review process showcases importance of incorporating feedback from a wider audience of stakeholders.
Latest:
Four-Steps to Accelerate Study Start-up CyclesIdentifying KPIs, benchmarks, key data points, and an actionable plan are all keys to accelerating study start-up cycles.
Latest:
How Today’s Digitally Driven Research Could Drive CAR T-cell Therapy Protocols of the FutureNew protocols, remote patient monitoring, and improved standards of care among ways industry can take next steps in CAR T-cell research.
Latest:
What Patients Expect from Clinical Trials in the COVID-19 EraKey takeaways from a survey of 250 oncology patients measuring COVID-19’s impact on patient willingness to participate in clinical trials.
Latest:
Targeting Patient PopulationKeys to ensuring your clinical trials better reflect your target population.
Latest:
At-home Self-collection of Blood Specimens for Safety Lab Testing in Clinical Trials via the Tasso+ DeviceLaboratory services organization focuses on easing patient and site burden with improved collection device.
Latest:
How to Address—and Overcome—Operational Challenges in Master Protocol StudiesTrials that address multiple questions simultaneously using a master protocol can be operationally complicated. These complexities can be managed, even in studies used to support a marketing application.
Latest:
Evaluation of Different NLP Models for Parsing and Extraction of Clinical Data from Scientific ArticlesNatural language processing models are able to automate the extraction of pertinent information from a vast array of scientific literature.
Latest:
The Impact of Automated Safety Document Distribution on Pharmacovigilance and Patient SafetyAutomating process can reduce time and resources lost from using manual steps and allows stakeholders to maintain compliance.
Latest:
Emerging Practices Employing CDISC Standards in Clinical TrialsNow that the industry has gotten some experience with CDISC standards, teams are aiming to get more from their standardization efforts.
Latest:
At-home Self-collection of Blood Specimens for Safety Lab Testing in Clinical Trials via the Tasso+ DeviceLaboratory services organization focuses on easing patient and site burden with improved collection device.
Latest:
Unknowns That Can Make or Break a Non-Opioid Analgesic Clinical TrialNew and renewed approaches to improve chances of success in developing non-addictive drugs for chronic pain.
Latest:
A Primer on Clinical Trial Virtual Waiting RoomsExploring their unique opportunity in increasing study enrollment levels.
Latest:
Establishing Metrics and Standardization for Non-CRF Data in EDCWhile Case Report Forms are a main contributor to collected data, non-CRF data such as core laboratory data and central imaging can be critical to any clinical study.
Latest:
From Words to Action: Advancing Efforts to Reduce the Racial Gap in Clinical ResearchDespite repeated calls from the FDA, patient advocates, and scholars for the need to address demographic disparities in clinical research, White participants still remain overrepresented while racial minority participants remain underrepresented in clinical trials.
Latest:
Introducing PALADINFirst-of-its-kind consortium dedicated to accelerating new medicines development through optimizing patient advocacy group—industry collaboration.
Latest:
Future of Clinical Trial Documentation Management: eTMF Integrated with BlockchaineTMF-blockchain technology offers a myriad of application benefits to data quality and integrity while ensuring compliance to ethical standards.
